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Abstract
Background: Influenza-like illness (ILI) is often defined as fever (>38.0°C) with cough or sore throat. In this study,
we tested the sensitivity, specificity, and positive and negative predictive values of this case definition in a
Cambodia patient population.
Methods: Passive clinic-based surveillance was established at nine healthcare centers to identify the causes of
acute undifferentiated fever in patients aged two years and older seeking treatment. Fever was defined as
tympanic membrane temperature >38°C lasting more than 24 hours and less than 10 days. Influenza virus
infections were identified by polymerase chain reaction.
Results: From July 2008 to December 2008, 2,639 patients were enrolled. From 884 (33%) patients positive for
influenza, 652 presented with ILI and 232 acute fever patients presented without ILI. Analysis by age group
identified no significant differences between influenza positive patients from the two groups. Positive predictive
values (PPVs) varied during the course of the influenza season and among age groups.
Conclusion: The ILI case definition can be used to identify a significant percentage of patients with influenza
infection during the influenza season in Cambodia, assisting healthcare providers in its diagnosis and treatment.
However, testing samples based on the criteria of fever alone increased our case detection by 34%.
Background
Globally, influenza is considered one of the most
important infectious diseases. It is reported that between
3 and 5 million cases of severe influenza disease occur
each year [1], with estimated annual influenza-associated
mortality between 500,000 and 1,000,000 cases (median
case-fatality of 190 deaths per 100,000 person infected
with influenza) [2,3]. Complicating the global influenza
burden is the recent recognition of a novel quad-
reassortment swine-origin influenza A virus which is the
agent associated with the WHO declared influenza pan-
demic [4].
Influenza viruses are transmitted through the respira-
tory route [5-8] and infections vary from asymptomatic
to severe, life threatening. Common clinical symptoms
of influenza include fever, cough, sore throat, headache,
muscle aches, nasal congestion and weakness [9]. These
symptoms can be non-specific and do not easily distin-
guish influenza from other respiratory viral syndromes
or other infectious etiologies in patients presenting for
healthcare services with acute febrile illness [10]. As
with any standardized syndromic disease case definition,
definitions of “influenza-like illness” (ILI) vary [11-13]
but typically include fever (≥ 38°C) with one or more
respiratory symptoms (e.g., cough or sore throat). These
clinical algorithms have been studied in children and
adults as part of hospital-based or age-specific antiviral
trials. These studies suggest that an ILI definition
including cough has a positive predictive value (PPV) of
60% to 87% [11,14,15]. Other work has focused on influ-
enza in hospitalized patients [16,17] and in national sur-
veillance activities [18]. The majority of these efforts
have focused on populations from developed countries,
whereas information on the predictive values of ILI
symptoms in developing countries is limited. * Correspondence: kaspernamru2@yahoo.com
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from rural Cambodian patients [19], we evaluated a
commonly used ILI definition, document fever and
cough or sore throat as a predictor of influenza disease.
As previous studies have suggested limiting the use of
clinical predictors for influenza to the influenza season
[15], the sampling included all eligible patients enrolled
during a single Cambodian influenza season.
Methods
Study site and population
In December 2006, a clinic and hospital-based acute
febrile illness surveillance was implemented at nine
Cambodian government medical clinics. Five of these
sites were located in Operational District A (peri-urban)
and four were in Operational District B (rural). All par-
ticipating field sites were within 50 kilometers of Phnom
Penh in south-central Cambodia. Patients were recruited
by study site staff if they had a recorded temperature ≥
38.0°C lasting at least 24 hours but not greater than
10 days, were two years of age or older, and, after medi-
cal examination, had no obvious source of infection.
A healthcare provider in each clinic obtained written
informed consent, administered a pre-tested enrollment
questionnaire, performed a medical examination and
collected clinical specimens per study protocol[19].
Influenza-like illness was defined according the WHO
guidelines, which included, documented fever (≥ 38.0°C)
and cough or sore throat. For this study, only patients
enrolled I the surveillance for acute febrile illness
from July 2008 through December 2008 were included
for analysis; corresponding to influenza season in
Cambodia.
Specimen Collection
For each enrolled patient, one throat and one nasal
swab were collected. For nasal swabs, a dry polyester
swab was inserted into the nostril parallel to the palate,
slowly withdrawn, and placed in a vial containing 2 - 3
milliliters of virus transport medium (VTM). For throat
swabs, both tonsils and the posterior pharynx were
swabbed vigorously, and the swab placed in 2 - 3 millili-
ters of VTM. All inoculated vials were kept at 4°C until
transported between 24 and 72 hours after collection to
the Naval Medical Research Unit No. 2 (NAMRU-2)
located at the campus of the Cambodian National Insti-
tute of Public Health (NIPH).
Laboratory testing
Ribonucleic acid (RNA) was extracted from nasal and
throat swabs using QIAamp viral RNA mini kits (QIA-
GEN, Hilden, Germany) following the manufacturer’s
instructions and stored at -70°C. The influenza virus
genome was detected using a reverse real-time PCR
(rRT-PCR) assay developed to detect influenza A/H1,
A/H3, A/H5, and B virus subtypes. Real-time assays
were developed at the Centers for Disease Control and
Prevention (Atlanta, GA, USA). Real time assays and
sequence information are available upon request from
Dr. Steve Lindstrom under the terms of a material
transfer agreement. One-step rRT-PCR was performed
in a final volume of 25 μl containing 5 μlo fe x t r a c t e d
RNA, 12.5 μl of buffer mix and 0.5 μl Superscript III/
Platinum Taq-Enzyme mix, 20 units of RNAse-out
(Invitrogen, Carlsbad, CA, USA), 0.8 μM for each
primer and 0.2 μM of probe. The Rotor-Gene 6000
real-time thermocyler (Corbett Life Science, Sydney,
Australia) was used for all PCR reactions. The thermo-
cycling parameters for all targets consisted of 50°C for
30 minutes, 95°C for 2 minutes, and 45 cycles with 95°C
for 15 seconds, 55°C for 30 seconds (US CDC, Atlanta,
GA, USA).
Statistical Analysis
All data was double-data entered into MS Access
(Microsoft Inc., Redmond, WA, USA). Data was
imported into SAS v9.1 (SAS, Cary, NC), which was
used for all statistical analyses. The definition of ILI
(fever and cough or sore throat) was analyzed to deter-
mine sensitivity, specificity,p o s i t i v ep r e d i c t i v ev a l v e
(PPV) and negative predictive value (NPV) comparing
patients with and without laboratory evidence of influ-
enza virus. Sensitivity was defined as the probability of
having the ILI given laboratory-confirmed influenza;
specificity was defined as the probability of not having
the ILI when the patient does not have laboratory-con-
firmed influenza. The PPV was the probability of having
laboratory-confirmed influenza when ILI was present;
NPV is the probability of not having laboratory-
confirmed influenza when ILI was not present[15]. Cate-
gorical data was analyzed by the use of either Chi-
Square (expected cell frequency > 5) or Fisher’s Exact
Test (expected cell frequency ≤5). Continuous data were
assessed for normality and if normally distributed, para-
metric statistics were used. If the data was non-normally
distributed, then non-parametric testing was used. All
statistical tests were two-tailed and significance was
defined as p < 0.05.
Ethical Considerations
Eligible subjects were voluntarily enrolled in accordance
with an Institutional Review Board protocol approved by
U.S. NAMRU-2 and the National Ethics Committee of
the Royal Kingdom of Cambodia, Ministry of Health.
Results
From July 2008 through December 2008, a total of 2,639
febrile patients were enrolled. The median age of
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(IQR) 6 - 25) and males accounted for 52.9% of enrolled
patients. The median day of patient presentation was at
3 days of fever duration (IQR 3 - 4) with a median tem-
perature of 39.0 (IQR 38.5 - 39.5). A more detailed
description of this population has been described
elsewhere [19].
Among the enrolled patients, the prevalence of labora-
tory-confirmed influenza was 33.5% (884) and the pro-
portion of patients with ILI was 62.2% (1,652). Based on
these values, the sensitivity and specificity of the ILI
cases definition to predict disease was 73.8% (652/884)
and 43.0% (755/1755), respectively. The PPV was 39.5%
(652/1652) and NPV was 76.5% (755/987). Among
enrolled patients, laboratory testing of patients using the
criteria of only fever increased the number of detected
cases from 652 to 884, a 34% increase.
Of the 884 laboratory-confirmed influenza cases, 69%
(608) and 31% (276) had influenza A and B types,
respectively. (Table 1) Among patients with influenza A
and B, ILI sensitivity was 76.0% (462/608) and 68%
(190/276), respectively suggesting that the ILI case defi-
nition was 1.4 times (95% confidence interval (CI): 1.03
to 1.99, p = 0.025) more sensitivity in detecting influ-
enza A as compared to than influenza B cases. Sensitiv-
ity did not differ between influenza H3 and H1 types.
When stratified by age groups (young children (ages
2-6), school aged children (ages 7-18) and adults (>18
years of age)), there was no detected statistically signifi-
cant difference for ILI sensitivity. However, there were
noted statistically significant differences by age group for
specificity (p < .0001), PPV (p = .01), and NPV (p < .0001).
(Table 2) For all three values, analysis suggested that
adults had higher specificity (53%), NPV (90%), and lower
PPV (21%) as compared to subjects in the younger
age groups.
When stratified by month, the PPV was lowest in July
for all age groups, peaking in October, and declined
thereafter (Table 3). While the monthly pattern was the
same for all, the PPV statistically differed by age group
for September through December. PPVs during these
months were lowest for adults, although 2 to 5 years
olds had lower rates than 7 to 18 year olds in
December. Over the entire period of study the PPVs for
age groups 2 to 6, 7 to 18, and >18 years was 44%, 49%
and 21% (p < .0001), respectively. Again, adults had the
lowest overall PPV.
From July to December 2008, ILI was documented in
43% to 68% of enrolled acute fever patients (Figure 1)
per month while the prevalence of influenza ranged
from 9.9% in July to a peak of 59.4% in October. ILI cri-
teria was met most often in December (68%), when the
prevalence of influenza was only 9.7%.
Discussion
Previous studies have reviewed the definition of ILI and
symptoms most commonly associated with influenza
disease, with most studies using hospitalized patients
[9,11-13]. This analysis evaluated the ability of an ILI-
defined syndrome to correctly identify patients with a
laboratory-confirmed influenza infection in Cambodia
patients seeking treatment for acute febrile illness. We
found that the ILI case definition was more sensitive for
patients infected with influenza A than influenza B, pos-
sibly reflecting milder disease among those infected
influenza B as described in previous studies [20,21].
Table 1 Patients (N = 2,639) presenting with influenza-
like illness and laboratory confirmed Influenza type
and subtype by clinical presentation of Influenza-like
Illness (ILI)
Influenza Status ILI NO ILI Total
Influenza (overall) 652 (73.8%)* 232 884
A † 462 (76.0%) 146 608
A/H1‡ 78 (74.2%) 27 105
A/H3 383 (76.3%) 119 502
A/H5 1 (100%) 0 1
B 190 (68.8%) 86 276
Negative 1000 755 1,755
* n (% positive for ILI).
† Odds ratio = 1.4 (95% confidence internals: 1.03 to 1.99, p = 0.025) for
frequency of ILI by influenza A (76.0%) and influenza B (68.8%) types.
‡ ILI for H1 (74.2%) vs. H3 (76.3%), p = .66.
Table 2 Sensitivity, Specificity, positive and negative
predictive value for a case definition of Influenza-like
Illness by presence or absence of laboratory-confirmed
influenza virus infection
Age (years) 2 to 6 7 to 18 >18 p-value
Sensitivity 76 (335)* 73 (401) 68 (148) .18
Specificity 32 (470) 37 (487) 53 (798) <.0001
Positive Predictive Value 44 (576) 49 (599) 21 (476) .01
Negative Predictive Value 66 (229) 63 (289) 90 (471) <.0001
* Percent (number tested).
Table 3 Positive predictive value of having influenza
virus given ILI symptoms stratified by age group and
enrollment month
Age (years) 2-6 7-18 >18 p-value
July 4 16 9 .10
August 22 24 19 .78
September 60 59 26 <.0001
October 65 73 33 <.0001
November 53 52 20 <.001
December 9 32 7 <.0001
OVERALL 44 49 21 <.0001
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changes in the prevalence of influenza infections
occurred. Hence the PPV appeared to peak in October,
at the peak of the influenza season. The sensitivity of
ILI case definition did not appear to vary with age.
However, the specificity appeared highest in adults rela-
tive to children suggesting that adults were less likely to
present with cough or sore throat than children possibly
due to acquired immunity to respiratory agents that
might induce ILI symptoms.
Laboratory testing patients only with ILI as enrollment
criteria would have identified 74% of the influenza cases
among enrolled patients. The definition of ILI for sur-
veillance purposes is sufficient as a testing strategy to
monitor seasonal influenza circulation and emerging
influenza strains. The ILI definition did not detect 26%
of cases in our clinic-based surveillance and may be
lacking for clinical practice and treatment guidelines
without laboratory testing to support the diagnosis.
The study enrollment criteria of reported fever dura-
tion for at least 24 hours does differ from the WHO ILI
definition that has no defined duration of fever. It is
possible that few patients seeking health care very early
in their illness may not meet study enrollment criteria
and therefore not been enrolled. However, the median
day of fever reported among patients upon enrollment
was three days with an IQR of 3-4 days, suggesting that
most Cambodian patients were unlikely to seek care
until well into their disease. In addition, further work is
needed to understand the healthcare seeking behavior of
this study population.
From August 2008-December 2008, the percentage of
febrile patients with ILI stayed constant study despite a
varying prevalence of influenza, suggesting that other
pathogens are contributing to febrile respiratory illness
in Cambodia. In addition to influenza virus, recent stu-
dies have identified other respiratory pathogens such as
human metapneumovirus [22], respiratory syncytial
virus, and parainfluenza virus 3 [23], adenovirus and rhi-
novirus from patients in developing countries; Further
studies are required to determine the contribution of
non-influenza respiratory pathogens among Cambodians
presenting with ILI. The pathogens endemic (e.g. den-
gue virus and malaria) to this region and the different
age groups they are most commonly detected in must
also be considered.
Previous studies have determined that the best use of
predictors is during the influenza season [15]. However,
these studies have focused on seasonal influenza in
developed nations and compared to these studies, the
PPV of ILI identified in Cambodia was lower, even at
the peak period of seasonal transmission. The range of
the monthly prevalence over the course of the influenza
season had considerable impact on the predictive values
and suggest that even within an influenza season the
use of clinical predictors may have limitations.
Conclusions
This study allowed us the unique opportunity to evalu-
ate an ILI definition among all patients with an acute
fever regardless of associated symptoms. Based on our
results, the ILI case definition can be used to identify a
significant percentage of patients with influenza infec-
tion during the influenza season in Cambodia. However,
testing samples based on the criteria of fever alone
increased our case detection by 34%. Surveillance for
acute fever provided a significant increase in the number
of influenza patients identified and should be considered
when determining the prevalence of influenza in a
population or when using clinical case definitions to
study the transmission of influenza among populations
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identify the majority of cases in a population presenting
for treatment, it may underestimate the true burden
of influenza disease among persons in resource-poor
regions.
Those patients without respiratory symptoms who
nonetheless tested positive for influenza are a reflection
of the difficulty of its clinical diagnosis, a difficulty com-
pounded by pathogens endemic to the region presenting
as acute undifferentiated febrile illness such as dengue,
malaria, typhoid fever, and other respiratory pathogens.
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